Response to Comments: Intravenous Immunoglobulin (IVIG)

This document is a response-to-comments notice for LCD L34580 (IVIG) stating the comment period (4/23/2020–7/7/2020), the notice period start (8/20/2020), and the effective date (10/4/2020). No provider comments were received and no coverage criteria changes are recorded in this notice.

"Notice records that the Intravenous Immunoglobulin (IVIG) LCD L34580 comment period ran 4/23/2020–7/7/2020, the notice period begins 8/20/2020, and the LCD becomes effective 10/4/2020; no comments ..."

Sign up to see full coverage criteria, indications, and limitations.